pirfenidone has been researched along with Keloid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maeda, T; Matsumura, H; Saito, M; Setoguchi, Y; Tsuboi, R; Yamazaki, M | 1 |
| Bloom, RF; Margolin, SB; Shetlar, CL; Shetlar, DJ; Shetlar, MR | 1 |
2 other study(ies) available for pirfenidone and Keloid
| Article | Year |
|---|---|
Pirfenidone suppresses keloid fibroblast-embedded collagen gel contraction.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Collagen Type I; Connective Tissue Growth Factor; Female; Fibroblasts; Gels; Humans; Keloid; Male; Pyridones; Skin; Transforming Growth Factor beta1 | 2012 |
Involution of keloid implants in athymic mice treated with pirfenidone or with triamcinolone.
Topics: Adult; Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Cell Transplantation; Electrophoresis, Cellulose Acetate; Female; Glucocorticoids; Glycosaminoglycans; Humans; Keloid; Male; Mice; Mice, Nude; Middle Aged; Pyridones; Triamcinolone | 1998 |